Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives
Nanotechnology is reshaping health care strategies and is expected to exert a tremendous
impact in the coming years offering better healthcare facilities. It has led to not only …
impact in the coming years offering better healthcare facilities. It has led to not only …
Theranostic nanoparticles
Theranostic nanoparticles hold the potential to revolutionize disease management. Over the
last decade, there has been growing interest in the engineering of various kinds of …
last decade, there has been growing interest in the engineering of various kinds of …
Gel–liposome‐mediated co‐delivery of anticancer membrane‐associated proteins and small‐molecule drugs for enhanced therapeutic efficacy
T Jiang, R Mo, A Bellotti, J Zhou… - Advanced Functional …, 2014 - Wiley Online Library
A programmed drug‐delivery system that can transport different anticancer therapeutics to
their distinct targets holds vast promise for cancer treatment. Herein, a core–shell‐based …
their distinct targets holds vast promise for cancer treatment. Herein, a core–shell‐based …
Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene
T Jiang, W Sun, Q Zhu, NA Burns… - Advanced Materials …, 2014 - pmc.ncbi.nlm.nih.gov
Graphical abstract A cellular protease-mediated graphene-based nanosystem is developed
for co-delivery of a membrane-associated cytokine (TRAIL) and an intracellular-acting small …
for co-delivery of a membrane-associated cytokine (TRAIL) and an intracellular-acting small …
Targeted radionuclide therapy of prostate cancer—from basic research to clinical perspectives
M Czerwińska, A Bilewicz, M Kruszewski… - Molecules, 2020 - mdpi.com
Prostate cancer is the most commonly diagnosed malignancy in men and the second
leading cause of cancer-related deaths in Western civilization. Although localized prostate …
leading cause of cancer-related deaths in Western civilization. Although localized prostate …
[HTML][HTML] Microbubbles and nanobubbles with ultrasound for systemic gene delivery
Y Endo-Takahashi, Y Negishi - Pharmaceutics, 2020 - mdpi.com
The regulation of gene expression is a promising therapeutic approach for many intractable
diseases. However, its use in clinical applications requires the efficient delivery of nucleic …
diseases. However, its use in clinical applications requires the efficient delivery of nucleic …
Targeted nanotechnology for cancer imaging
Targeted nanoparticle imaging agents provide many benefits and new opportunities to
facilitate accurate diagnosis of cancer and significantly impact patient outcome. Due to the …
facilitate accurate diagnosis of cancer and significantly impact patient outcome. Due to the …
[HTML][HTML] Prostate-specific membrane antigen as a target for cancer imaging and therapy
The prostate-specific membrane antigen (PSMA) is a molecular target whose use has
resulted in some of the most productive work toward imaging and treating prostate cancer …
resulted in some of the most productive work toward imaging and treating prostate cancer …
Recent advances in delivery of drug–nucleic acid combinations for cancer treatment
Cancer treatment that uses a combination of approaches with the ability to affect multiple
disease pathways has been proven highly effective in the treatment of many cancers …
disease pathways has been proven highly effective in the treatment of many cancers …
Theranostics: are we there yet?
S Svenson - Molecular pharmaceutics, 2013 - ACS Publications
The US National Institutes of Health through the National Cancer Institute (NCI) have been
charged with the goal of eliminating death and suffering from cancer by the year 2015. In …
charged with the goal of eliminating death and suffering from cancer by the year 2015. In …